MIRACLE stands for ‘Integrated multi-angle research and training network to eradicate leukemia minimal residual disease’. It is an international, multidisciplinary and multisectoral training program and funded by the European Union’s Horizon Europe’s Research and Innovation Program as a Marie Sklodowska-Curie Actions doctoral network. MIRACLE is an international, multidisciplinary and multisectoral training program consisting of 23 academic and non-academic partners from 8 EU countries (The Netherlands, Belgium, Germany, France, Spain, Italy, Czech Republic, United Kingdom) and will address one of the greatest challenges in leukemia treatment; the persistence of therapy-resistant cancer cells, known as minimal residual disease (MRD). The project will not only generate impactful research but also actively contribute to Europe’s Mission Cancer goal of increasing cure rates and improving the lives of cancer patients.
Recruiting highly motivated PhD candidates
By employing 10 highly talented doctoral candidates, MIRACLE aims to execute cutting-edge studies in several academic and industrial institutes while training the PhD students in multidisciplinary and transferable skills. The 10 researchers will tackle the problem of MRD in an integrated collaborative effort to prevent MRD-induced leukemia relapses and to drastically increase survival chances of leukemia patients. They will work on individual research projects and benefit from a comprehensive program that contains scientific, technical, and entrepreneurial training.
More information
- Please find the Job Vacancy, the MIRACLE Research Project descriptions and the application form at the website >
- Below find the MIRACLE recruitment flyer.
- The job vacancy for the 10 PhD positions is also published at Euraxess, at NatureCareers and in the EHA communication channels (Deadline first selection is 15 February 2025).
For further information and questions, please send an e-mail to Jan Stuchly (@email).